Prevention of Atrial Fibrillation by the Prescription of Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
Phase of Trial: Phase III
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Ramipril (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms PREFACE
- 27 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 23 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Jan 2014 Planned End Date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.